142 related articles for article (PubMed ID: 12738779)
1. Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.
Pan W; Arnone M; Kendall M; Grafstrom RH; Seitz SP; Wasserman ZR; Albright CF
J Biol Chem; 2003 Jul; 278(30):27820-7. PubMed ID: 12738779
[TBL] [Abstract][Full Text] [Related]
2. A unique substrate binding mode discriminates membrane type-1 matrix metalloproteinase from other matrix metalloproteinases.
Kridel SJ; Sawai H; Ratnikov BI; Chen EI; Li W; Godzik A; Strongin AY; Smith JW
J Biol Chem; 2002 Jun; 277(26):23788-93. PubMed ID: 11959855
[TBL] [Abstract][Full Text] [Related]
3. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
[TBL] [Abstract][Full Text] [Related]
4. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
Nagase H; Fields CG; Fields GB
J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
[TBL] [Abstract][Full Text] [Related]
5. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
[TBL] [Abstract][Full Text] [Related]
6. Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently synthetic substrates containing unusual amino acids in their P1' positions.
Mucha A; Cuniasse P; Kannan R; Beau F; Yiotakis A; Basset P; Dive V
J Biol Chem; 1998 Jan; 273(5):2763-8. PubMed ID: 9446583
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
[TBL] [Abstract][Full Text] [Related]
8. The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain.
Amano T; Kwak O; Fu L; Marshak A; Shi YB
Cell Res; 2005 Mar; 15(3):150-9. PubMed ID: 15780176
[TBL] [Abstract][Full Text] [Related]
9. Understanding the P1' specificity of the matrix metalloproteinases: effect of S1' pocket mutations in matrilysin and stromelysin-1.
Welch AR; Holman CM; Huber M; Brenner MC; Browner MF; Van Wart HE
Biochemistry; 1996 Aug; 35(31):10103-9. PubMed ID: 8756473
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.
Deng SJ; Bickett DM; Mitchell JL; Lambert MH; Blackburn RK; Carter HL; Neugebauer J; Pahel G; Weiner MP; Moss ML
J Biol Chem; 2000 Oct; 275(40):31422-7. PubMed ID: 10906330
[TBL] [Abstract][Full Text] [Related]
11. Catalytic- and ecto-domains of membrane type 1-matrix metalloproteinase have similar inhibition profiles but distinct endopeptidase activities.
Hurst DR; Schwartz MA; Ghaffari MA; Jin Y; Tschesche H; Fields GB; Sang QX
Biochem J; 2004 Feb; 377(Pt 3):775-9. PubMed ID: 14533979
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Minond D; Lauer-Fields JL; Nagase H; Fields GB
Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
[TBL] [Abstract][Full Text] [Related]
13. Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta 2 integrins.
Stefanidakis M; Bjorklund M; Ihanus E; Gahmberg CG; Koivunen E
J Biol Chem; 2003 Sep; 278(36):34674-84. PubMed ID: 12824186
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
[TBL] [Abstract][Full Text] [Related]
15. Active site specificity profiling of the matrix metalloproteinase family: Proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses.
Eckhard U; Huesgen PF; Schilling O; Bellac CL; Butler GS; Cox JH; Dufour A; Goebeler V; Kappelhoff R; Keller UAD; Klein T; Lange PF; Marino G; Morrison CJ; Prudova A; Rodriguez D; Starr AE; Wang Y; Overall CM
Matrix Biol; 2016 Jan; 49():37-60. PubMed ID: 26407638
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Amano T; Fu L; Sahu S; Markey M; Shi YB
Int J Mol Med; 2004 Aug; 14(2):233-9. PubMed ID: 15254771
[TBL] [Abstract][Full Text] [Related]
17. Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26.
Park HI; Turk BE; Gerkema FE; Cantley LC; Sang QX
J Biol Chem; 2002 Sep; 277(38):35168-75. PubMed ID: 12119297
[TBL] [Abstract][Full Text] [Related]
18. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
Shoari A; Rasaee MJ; Kanavi MR; Daraei B
J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
[TBL] [Abstract][Full Text] [Related]
19. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
20. Development of selective inhibitors and substrate of matrix metalloproteinase-12.
Devel L; Rogakos V; David A; Makaritis A; Beau F; Cuniasse P; Yiotakis A; Dive V
J Biol Chem; 2006 Apr; 281(16):11152-60. PubMed ID: 16481329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]